Patents by Inventor Melissa Beall
Melissa Beall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20160130353Abstract: The invention provides canine CD20 specific antibodies, methods of making the antibodies and methods of use of the antibodies.Type: ApplicationFiled: January 1, 2016Publication date: May 12, 2016Inventor: Melissa Beall
-
Patent number: 8980274Abstract: The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.Type: GrantFiled: January 21, 2011Date of Patent: March 17, 2015Assignee: IDEXX Laboratories, Inc.Inventors: Eugene Regis Krah, III, Melissa Beall, Thomas Patrick O'Connor, Jr., Ramaswamy Chandrashekar
-
Patent number: 8658387Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.Type: GrantFiled: November 30, 2010Date of Patent: February 25, 2014Assignee: IDEXX Laboratories, Inc.Inventors: Eugene Regis Krah, III, Melissa Beall
-
Publication number: 20110182925Abstract: The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.Type: ApplicationFiled: January 21, 2011Publication date: July 28, 2011Inventors: Eugene Regis Krah III, Melissa Beall, Thomas Patrick O'Connor, JR., Ramaswamy Chandrashekar
-
Publication number: 20110091995Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.Type: ApplicationFiled: November 30, 2010Publication date: April 21, 2011Inventors: EUGENE REGIS KRAH, III, MELISSA BEALL
-
Patent number: 7888054Abstract: The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.Type: GrantFiled: October 31, 2008Date of Patent: February 15, 2011Assignee: IDEXX Laboratories, Inc.Inventors: Eugene Regis Krah, III, Melissa Beall, Thomas Patrick O'Connor, Jr., Ramaswamy Chandrashekar
-
Patent number: 7842473Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.Type: GrantFiled: April 4, 2006Date of Patent: November 30, 2010Assignee: IDEXX Laboratories, Inc.Inventors: Eugene Regis Krah, III, Melissa Beall
-
Patent number: 7842474Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.Type: GrantFiled: October 4, 2006Date of Patent: November 30, 2010Assignee: IDEXX Laboratories, Inc.Inventors: Eugene Regis Krah, III, Thomas Patrick O'Connor, Jr., Melissa Beall
-
Patent number: 7771959Abstract: Isolated nucleic acid molecules having a nucleotide sequence encoding canine pancreatic lipase polypeptides, allelic variants and fragments thereof. Vectors and host cells containing the polynucleotide sequences and methods for expressing the polypeptides. Monoclonal antibodies that specifically binds to the canine pancreatic lipase polypeptides. Cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of canine pancreatic lipase in a biological sample. The methods include using the monoclonal antibodies to specifically bind to canine pancreatic lipase polypeptides. The method includes using standards of recombinant canine pancreatic lipase. Devices and kits for performing methods for detecting canine pancreatic lipase in biological samples.Type: GrantFiled: April 15, 2005Date of Patent: August 10, 2010Assignee: IDEXX Laboratories, Inc.Inventors: Melissa Beall, Stacey Pazar Huth, Eugene Regis Krah
-
Patent number: 7722875Abstract: Isolated nucleic acid molecules having a nucleotide sequence encoding canine pancreatic lipase polypeptides, allelic variants and fragments thereof. Vectors and host cells containing the polynucleotide sequences and methods for expressing the polypeptides. Monoclonal antibodies that specifically binds to the canine pancreatic lipase polypeptides. Cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of canine pancreatic lipase in a biological sample. The methods include using the monoclonal antibodies to specifically bind to canine pancreatic lipase polypeptides. The method includes using standards of recombinant canine pancreatic lipase. Devices and kits for performing methods for detecting canine pancreatic lipase in biological samples.Type: GrantFiled: July 13, 2007Date of Patent: May 25, 2010Assignee: IDEXX Laboratories, Inc.Inventors: Melissa Beall, Stacey Pazar Huth, Eugene Regis Krah
-
Patent number: 7585621Abstract: A method and device for determining whether an animal is infected with West Nile Virus (WNV), or is either not infected or vaccinated with a WNV vaccine. The method includes contacting a biological sample from the subject with a first WNV polypeptide that is not an element of the WNV vaccine, and detecting whether antibodies in the sample bind to the WNV polypeptide. If the antibodies in the sample bind to the WNV polypeptide, it can be determined that the animal is naturally infected with WNV and if the antibodies do not bind to the polypeptide, it can be determined that the animal is either vaccinated or not infected.Type: GrantFiled: September 9, 2004Date of Patent: September 8, 2009Assignee: IDEXX Laboratories, Inc.Inventors: Melissa Beall, Ramaswamy Chandrashekar
-
Publication number: 20090110691Abstract: The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.Type: ApplicationFiled: October 31, 2008Publication date: April 30, 2009Inventors: Eugene Regis Krah, III, Melissa Beall, Thomas Patrick O'Connor, JR., Ramaswamy Chandrashekar
-
Publication number: 20090004217Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.Type: ApplicationFiled: October 4, 2006Publication date: January 1, 2009Inventors: Eugene Regis Krah, III, Thomas Patrick O'Connor, Melissa Beall
-
Publication number: 20080227194Abstract: Isolated nucleic acid molecules having a nucleotide sequence encoding canine pancreatic lipase polypeptides, allelic variants and fragments thereof. Vectors and host cells containing the polynucleotide sequences and methods for expressing the polypeptides. Monoclonal antibodies that specifically binds to the canine pancreatic lipase polypeptides. Cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of canine pancreatic lipase in a biological sample. The methods include using the monoclonal antibodies to specifically bind to canine pancreatic lipase polypeptides. The method includes using standards of recombinant canine pancreatic lipase. Devices and kits for performing methods for detecting canine pancreatic lipase in biological samples.Type: ApplicationFiled: July 13, 2007Publication date: September 18, 2008Applicant: IDEXX Laboratories, Inc.Inventors: Melissa Beall, Stacey Pazar Huth, Eugene Regis Krah
-
Publication number: 20080045700Abstract: The invention provides canine CD20 nucleotide and protein sequences. These compositions are useful in the diagnosis and treatment of, e.g., CD20+ B-cell lymphoma, immune-mediated hemolytic anemia, immune-mediated thrombocytopenia, and systemic lupus erythematosus (SLE) in canines and felines.Type: ApplicationFiled: July 26, 2007Publication date: February 21, 2008Inventor: Melissa Beall
-
Publication number: 20060234322Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.Type: ApplicationFiled: April 4, 2006Publication date: October 19, 2006Inventors: Eugene Krah, Melissa Beall
-
Publication number: 20050271662Abstract: The invention provides canine CD20 nucleotide and protein sequences. These compositions are useful in the diagnosis and treatment of, e.g., CD20+ B-cell lymphoma, immune-mediated hemolytic anemia, immune-mediated thrombocytopenia, and systemic lupus erythematosus (SLE) in canines and felines.Type: ApplicationFiled: May 26, 2005Publication date: December 8, 2005Inventor: Melissa Beall
-
Publication number: 20050233368Abstract: Isolated nucleic acid molecules having a nucleotide sequence encoding canine pancreatic lipase polypeptides, allelic variants and fragments thereof. Vectors and host cells containing the polynucleotide sequences and methods for expressing the polypeptides. Monoclonal antibodies that specifically binds to the canine pancreatic lipase polypeptides. Cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of canine pancreatic lipase in a biological sample. The methods include using the monoclonal antibodies to specifically bind to canine pancreatic lipase polypeptides. The method includes using standards of recombinant canine pancreatic lipase. Devices and kits for performing methods for detecting canine pancreatic lipase in biological samples.Type: ApplicationFiled: April 15, 2005Publication date: October 20, 2005Applicant: IDEXX Laboratories, Inc.Inventors: Melissa Beall, Stacey Huth, Eugene Krah
-
Publication number: 20050053923Abstract: A method and device for determining whether an animal is infected with West Nile Virus (WNV), or is either not infected or vaccinated with a WNV vaccine. The method includes contacting a biological sample from the subject with a first WNV polypeptide that is not an element of the WNV vaccine, and detecting whether antibodies in the sample bind to the WNV polypeptide. If the antibodies in the sample bind to the WNV polypeptide, it can be determined that the animal is naturally infected with WNV and if the antibodies do not bind to the polypeptide, it can be determined that the animal is either vaccinated or not infected.Type: ApplicationFiled: September 9, 2004Publication date: March 10, 2005Applicant: IDEXX Laboratories, Inc.Inventors: Melissa Beall, Ramaswamy Chandrashekar